Cargando…

Current Knowledge on Microviridin from Cyanobacteria

Cyanobacteria are a rich source of secondary metabolites with a vast biotechnological potential. These compounds have intrigued the scientific community due their uniqueness and diversity, which is guaranteed by a rich enzymatic apparatus. The ribosomally synthesized and post-translationally modifie...

Descripción completa

Detalles Bibliográficos
Autores principales: do Amaral, Samuel Cavalcante, Monteiro, Patrick Romano, Neto, Joaquim da Silva Pinto, Serra, Gustavo Marques, Gonçalves, Evonnildo Costa, Xavier, Luciana Pereira, Santos, Agenor Valadares
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823629/
https://www.ncbi.nlm.nih.gov/pubmed/33406599
http://dx.doi.org/10.3390/md19010017
_version_ 1783639881200697344
author do Amaral, Samuel Cavalcante
Monteiro, Patrick Romano
Neto, Joaquim da Silva Pinto
Serra, Gustavo Marques
Gonçalves, Evonnildo Costa
Xavier, Luciana Pereira
Santos, Agenor Valadares
author_facet do Amaral, Samuel Cavalcante
Monteiro, Patrick Romano
Neto, Joaquim da Silva Pinto
Serra, Gustavo Marques
Gonçalves, Evonnildo Costa
Xavier, Luciana Pereira
Santos, Agenor Valadares
author_sort do Amaral, Samuel Cavalcante
collection PubMed
description Cyanobacteria are a rich source of secondary metabolites with a vast biotechnological potential. These compounds have intrigued the scientific community due their uniqueness and diversity, which is guaranteed by a rich enzymatic apparatus. The ribosomally synthesized and post-translationally modified peptides (RiPPs) are among the most promising metabolite groups derived from cyanobacteria. They are interested in numerous biological and ecological processes, many of which are entirely unknown. Microviridins are among the most recognized class of ribosomal peptides formed by cyanobacteria. These oligopeptides are potent inhibitors of protease; thus, they can be used for drug development and the control of mosquitoes. They also play a key ecological role in the defense of cyanobacteria against microcrustaceans. The purpose of this review is to systematically identify the key characteristics of microviridins, including its chemical structure and biosynthesis, as well as its biotechnological and ecological significance.
format Online
Article
Text
id pubmed-7823629
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78236292021-01-24 Current Knowledge on Microviridin from Cyanobacteria do Amaral, Samuel Cavalcante Monteiro, Patrick Romano Neto, Joaquim da Silva Pinto Serra, Gustavo Marques Gonçalves, Evonnildo Costa Xavier, Luciana Pereira Santos, Agenor Valadares Mar Drugs Review Cyanobacteria are a rich source of secondary metabolites with a vast biotechnological potential. These compounds have intrigued the scientific community due their uniqueness and diversity, which is guaranteed by a rich enzymatic apparatus. The ribosomally synthesized and post-translationally modified peptides (RiPPs) are among the most promising metabolite groups derived from cyanobacteria. They are interested in numerous biological and ecological processes, many of which are entirely unknown. Microviridins are among the most recognized class of ribosomal peptides formed by cyanobacteria. These oligopeptides are potent inhibitors of protease; thus, they can be used for drug development and the control of mosquitoes. They also play a key ecological role in the defense of cyanobacteria against microcrustaceans. The purpose of this review is to systematically identify the key characteristics of microviridins, including its chemical structure and biosynthesis, as well as its biotechnological and ecological significance. MDPI 2021-01-04 /pmc/articles/PMC7823629/ /pubmed/33406599 http://dx.doi.org/10.3390/md19010017 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
do Amaral, Samuel Cavalcante
Monteiro, Patrick Romano
Neto, Joaquim da Silva Pinto
Serra, Gustavo Marques
Gonçalves, Evonnildo Costa
Xavier, Luciana Pereira
Santos, Agenor Valadares
Current Knowledge on Microviridin from Cyanobacteria
title Current Knowledge on Microviridin from Cyanobacteria
title_full Current Knowledge on Microviridin from Cyanobacteria
title_fullStr Current Knowledge on Microviridin from Cyanobacteria
title_full_unstemmed Current Knowledge on Microviridin from Cyanobacteria
title_short Current Knowledge on Microviridin from Cyanobacteria
title_sort current knowledge on microviridin from cyanobacteria
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823629/
https://www.ncbi.nlm.nih.gov/pubmed/33406599
http://dx.doi.org/10.3390/md19010017
work_keys_str_mv AT doamaralsamuelcavalcante currentknowledgeonmicroviridinfromcyanobacteria
AT monteiropatrickromano currentknowledgeonmicroviridinfromcyanobacteria
AT netojoaquimdasilvapinto currentknowledgeonmicroviridinfromcyanobacteria
AT serragustavomarques currentknowledgeonmicroviridinfromcyanobacteria
AT goncalvesevonnildocosta currentknowledgeonmicroviridinfromcyanobacteria
AT xavierlucianapereira currentknowledgeonmicroviridinfromcyanobacteria
AT santosagenorvaladares currentknowledgeonmicroviridinfromcyanobacteria